# Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

> **NCT03822520** · PHASE1 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 28 (actual)

## Conditions studied

- Qt Interval, Variation in

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Moxifloxacin
- **OTHER:** Water

## Key facts

- **NCT ID:** NCT03822520
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-30
- **Primary completion:** 2018-05-25
- **Final completion:** 2018-05-25
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03822520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03822520, "Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03822520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*